Pricing

Cidara Therapeutics Inc (CDTX)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jeffrey L. Stein
Employees:
90
6310 NANCY RIDGE DRIVE, SUITE 101, SAN DIEGO, CA, 92121
858-752-6170
Cidara Therapeutics, Inc. focuses on the discovery, development, and commercialization of long-acting anti-infectives. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available